Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_220_библиотеки_им_акад_М_И_Перельмана
.pdf
151
18. Ратманова, А. Обновленные рекомендации AHA/ACC по ведению
больных с инфарктом миокарда с подъемом сегмента ST (2007): Клинические
рекомендации / А. Ратманова // Medicine Review. Кардиология. – 2008. – № 1. – С.
20–26.
19. Смертность населения от различных болезней системы
кровообращения в Москве и Санкт-Петербурге в 2015 и 2018 годах / С. А. Бойцов,
Е. З. Голухова, О. М. Драпкина [и др.] // Российский кардиологический журнал. –
2021. – Т. 26, № 1. – С. 73–78.
20. Эмбологенный инфаркт миокарда: взгляд эндоваскулярного хирурга /
А. А. Фролов, Е. Г. Шарабрин, А. Г. Савенков, С. Н. Ботова // Кардиология:
новости, мнения, обучение. – 2016. – № 2. – С. 54–58.
21. Яковлева, Л. Н. Повреждение миокарда / Л. Н. Яковлева, О. Э. Матузок
// Медицина неотложных состояний. – 2020. – Т. 16, № 1. – С. 11–15.
22. 2017 ESC Guidelines for the management of acute myocardial infarction in
patients presenting with ST-segment elevation: The Task Force for the management of
acute myocardial infarction in patients presenting with ST-segment elevation of the
European Society of Cardiology (ESC) / B. Ibanez, S. James, S. Agewall [et al.] //
European heart journal. – 2018. – Vol. 39, № 2. – P. 119–177.
23. A systematic review on the triggers and clinical features of type 2 myocardial
infarction / G. Wang, N. Zhao, S. Zhong, J. Li // Clinical cardiology. – 2019. – Vol. 42,
№ 10. – P. 1019–1027.
24. Anitschkow, N. Üeber experimentelle cholesterinsteatose und ihre
bedeutung für die entstehung einiger pathologischer prozesse / N. Anitschkow, S.
Chalatow // Zentralblatt fu
r allgemeine Pathologie und pathologische Anatomie. – 1913.
– Vol. 24, № 1. – P. 1–9.
25. Assessment and treatment of patients with type 2 myocardial infarction and
acute nonischemic myocardial injury / A. P. DeFilippis, A. R. Chapman, N. L. Mills [et
al.] // Circulation. – 2019. – Vol. 140, № 20. – P. 1661–1678.
26. Attributes to Hektoen L – anonymous infarction of the heart // The Journal
of the American Medical Association. – 1899. – Vol. 33. – P. 919.
https://t.me/med1917
152
27. Braunwald, E. Evolution of the management of acute myocardial infarction:
a 20th century saga / E. Braunwald // Lancet. – 1998. – Vol. 352, № 9142. – P. 1771–
1774.
28. Brinkmann, C. 4th universal definition of myocardial infarction 2018: What
is new? / C. Brinkmann, J. Schofer // Herz. – 2018. – Vol. 43, № 8. – P. 681–688.
29. Bugiardini, R. Angina with “normal” coronary arteries: a changing
philosophy / R. Bugiardini, C. N. Bairey Merz // The Journal of the American Medical
Association. – 2005. – Vol. 293, № 4. – P. 477–484.
30. Cairns, J. A. Myocardial infarction size: measurement and modification / J.
A. Cairns // Canadian Medical Association journal. – 1977. – Vol. 117, № 3. – P. 255–
262.
31. Cardiac troponin changes to distinguish type 1 and type 2 myocardial
infarction and 180-day mortality risk / Y. Sandoval, S. E. Thordsen, S. W. Smith [et al.]
// European heart journal. Acute cardiovascular care. – 2014. – Vol. 3, № 4. – P. 317–
325.
32. Cardiovascular mortality after type 1 and type 2 myocardial infarction in
young adults / A. Singh, A. Gupta, E. M. DeFilippis [et al.] // Journal of the American
College of Cardiology. – 2020. – Vol. 75, № 9. – P. 1003–1013.
33. Chapman, A. R. Assessment and classification of patients with myocardial
injury and infarction in clinical practice / A. R. Chapman, P. D. Adamson, N. L. Mills //
Heart. – 2017. – Vol. 103, № 1. – P. 10–18.
34. Characteristics and occurrence of type 2 myocardial infarction in emergency
department patients: a prospective study / J. H. Greenslade, T. Adikari, C. Mueller [et al.]
// Emergency medicine journal. – 2017. – Vol. 35, № 3. – P. 169–175.
35. Classification of myocardial infarction: frequency and features of type 2
myocardial infarction / L. Saaby, T. S. Poulsen, S. Hosbond [et al.] // The American
journal of medicine. – 2013. – Vol. 126, № 9. – P. 789–797.
36. Clinical characteristics and outcomes of patients with myocardial infarction,
myocardial injury, and nonelevated troponins / L. Sarkisian, L. Saaby, T. S. Poulsen [et
al.] // The American journal of medicine. – 2016. – Vol. 129, № 4. – P. 446e.5–446e.21.
https://t.me/med1917
153
37. Clinical characteristics, aetiology and occurrence of type 2 acute myocardial
infarction / F. M. Szymański, G. Karpiński, A. E. Płatek [et al.] // Kardiologia polska. –
2014. – Vol. 72, № 4. – P. 339–344.
38. Clinical features and prognosis of type 2 myocardial infarction in vasospastic
angina / Y. Matsue, K. Yoshida, M. Hoshino [et al.] // The American journal of medicine.
– 2015. – Vol. 128, № 4. – P. 389–395.
39. Collinson, P. O. Type 2 myocardial infarction / P. O. Collinson // Heart. –
2015. – Vol. 101, № 2. – P. 89–90.
40. Coronary artery spasm: new insights / A. Matta, F. Bouisset, T. Lhermusier
[et al.] // Journal of interventional cardiology. – 2020. – Vol. 2020. – Article ID 5894586.
41. Coronary optical coherence tomography and cardiac magnetic resonance
imaging to determine underlying causes of myocardial infarction with nonobstructive
coronary arteries in women / H. R. Reynolds, A. Maehara, R. Y. Kwong [et al.] //
Circulation. – 2021. – Vol. 143, № 7. – P. 624–640.
42. Diagnosis of type I versus type II myocardial infarction in Emergency
Department Patients with ischemic symptoms / S. W. Smith, L. A. Pearce, M. M.
Murakami, F. S. Apple // Annals of Emergency Medicine. – 2011. – Vol. 58, № 4. – P.
S211–S212.
43. Diagnostic and therapeutic implications of type 2 myocardial infarction:
review and commentary / J. S. Alpert, K. A. Thygesen, H. D. White, A. S. Jaffe // The
American journal of medicine. – 2014. – Vol. 127, № 2. – P. 105–108.
44. Different causes of death in patients with myocardial infarction type 1, type
2, and myocardial injury / S. Lambrecht, L. Sarkisian, L. Saaby [et al.] // The American
journal of medicine. – 2018. – Vol. 131, № 5. – P. 548–554.
45. Differential diagnostic factors of type 1 and type 2 myocardial infarction in
patients with elevated cardiac troponin levels / Y. Seo, J. Paik, S. Shin [et al.] // Clinical
and experimental emergency medicine. – 2020. – Vol. 7, № 3. – P. 213–219.
46. Discrimination of patients with type 2 myocardial infarction / J. T. Neumann,
N. A. Sörensen, N. Rübsamen [et al.] // European heart journal. – 2017. – Vol. 38, № 47.
– P. 3514–3520.
https://t.me/med1917
154
47. Edler, I. The use of ultrasonic reflectoscope for the continuous recording of
movements of heart walls / I. Edler, C. H. Hertz // Kungliga Fysiografiska Sällskapets i
Lund Förhandlingar. – 1954. – Vol. 24, № 5.
48. Effect of the novel thienopyridine prasugrel compared with clopidogrel on
spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in
Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in
Myocardial Infarction 38: an application of the classification system from the universal
definition of myocardial infarction / D. A. Morrow, S. D. Wiviott, H. D. White [et al.] //
Circulation. – 2009. – Vol. 119, № 21. – P. 2758–2764.
49. Embolic myocardial infarction as a consequence of atrial fibrillation: a
prevailing disease of the future / F. D. Kolodgie, R. Virmani, A. V. Finn, M. E. Romero
// Circulation. – 2015. – Vol. 132, № 4. – P. 223–226.
50. ESC working group position paper on myocardial infarction with non-
obstructive coronary arteries / S. Agewall, J. F. Beltrame, H. R. Reynolds [et al.] //
European heart journal. – 2017. – Vol. 38, № 3. – P. 143–153.
51. Fourth universal definition of myocardial infarction / K. Thygesen, J. S.
Alpert, A. S. Jaffe [et al.] // Circulation. – 2018. – Vol. 138, № 20. – P. e618–e651.
52. Friedberg, C. K. Acute myocardial infarction not due to coronary artery
occlusion / C. K. Friedberg, H. Horn // The Journal of the American Medical Association.
– 1939. – Vol. 112. – P. 1675–1679.
53. Global Health Estimates: Life expectancy and leading causes of death and
disability. – Text : electronic // World Health Organization : website. – 2019. – URL:
http://www.who.int/healthinfo/mortality_data/en/ (date of request: 20.01.2020).
54. Identification of myocardial injury in the emergency setting / P. A. Kavsak,
A. Worster, J. J. You [et al.] // Clinical biochemistry. – 2010. – Vol. 43, № 6. – P. 539–
544.
55. Impact on long-term mortality of presence of obstructive coronary artery
disease and classification of myocardial infarction / T. Baron, K. Hambraeus, J.
Sundström [et al.] // The American journal of medicine. – 2016. – Vol. 129, № 4. – P.
398–406.
https://t.me/med1917
155
56. Incidence, frequency, and clinical characteristics of type 3 myocardial
infarction in clinical practice / N. Jangaard, L. Sarkisian, L. Saaby [et al.] // The American
journal of medicine. – 2017. – Vol. 130, № 7. – P. 862.e9–862.e14.
57. Introduction of high-sensitivity troponin assays: impact on myocardial
infarction incidence and prognosis / T. Reichlin, R. Twerenbold, M. Reiter [et al.] // The
American journal of medicine. – 2012. – Vol. 125, № 12. – P. 1205–1213.
58. Kommentar zur dritten allgemeinen Definition des Myokardinfarktes der
gemeinschaftlichen ESC/ ACCF/AHA/WHF Task Force / N. Schofer, C. Hamm, H. F.
Katus [et al.] // Der Kardiologe. – 2014. – Vol. 8, № 1. – P. 65–71.
59. Lippi, G. Cardiac troponins and mortality in type 1 and 2 myocardial
infarction / G. Lippi, F. Sanchis-Gomar, G. Cervellin // Clinical chemistry and laboratory
medicine. – 2017. – Vol. 55, № 2. – P. 181–188.
60. London, M. J. Type 2 perioperative myocardial infarction: can we close
Pandora's box? / M. J. London // Anesthesiology. – 2018. – Vol. 128, № 6. – P. 1055–
1059.
61. Long-term prognosis of patients with myocardial infarction type 1 and type
2 with and without involvement of coronary vasospasm / R. Sato, K. Sakamoto, K.
Kaikita [et al.] // Journal of clinical medicine. – 2020. – Vol. 9, № 6. – Article 1686.
62. Master, A. M. Postoperative coronary artery occlusion / A. M. Master, S.
Dack, H. L. Jaffe // The Journal of the American Medical Association. – 1938. – Vol.
110. – P. 1415–1418.
63. Melberg, T. The impact of the 2007 ESC-ACC-AHA-WHF Universal
definition on the incidence and classification of acute myocardial infarction: a
retrospective cohort study / T. Melberg, R. Burman, K. Dickstein // International journal
of cardiology. – 2010. – Vol. 139, № 3. – P. 228–233.
64. Meta-analysis comparing outcomes of type 2 myocardial infarction and type
1 myocardial infarction with a focus on dual antiplatelet therapy / C. Reid, A. Alturki, A.
Yan [et al.] // CJC open. – 2020. – Vol. 2, № 3. – P. 118–128.
https://t.me/med1917
156
65. Mihatov, N. Type 2 myocardial infarction due to supply–demand mismatch
/ N. Mihatov, J. L. Jr. Januzzi, H. K. Gaggin // Trends in cardiovascular medicine. – 2017.
– Vol. 27, № 6. – P. 408–417.
66. Modifiable risk factors, cardiovascular disease, and mortality in 155 722
individuals from 21 high-income, middle-income, and low-income countries (PURE): a
prospective cohort study / S. Yusuf, P. Joseph, S. Rangarajan [et al.] // Lancet. – 2020. –
Vol. 395, № 10226. – P. 795–808.
67. Mortality rate in type 2 myocardial infarction: observations from an
unselected hospital cohort / L. Saaby, T. S. Poulsen, A. C. P. Diederichsen [et al.] // The
American journal of medicine. – 2014. – Vol. 127, № 4. – P. 295–302.
68. Myocardial infarction redefined – a consensus document of The Joint
European Society of Cardiology/American College of Cardiology Committee for the
redefinition of myocardial infarction / J. S. Alpert, K. Thygesen, E. Antman, J. P. Bassand
// Journal of the American College of Cardiology. – 2000. – Vol. 36, № 3. – P. 959–969.
69. Myocardial infarction type 2: avoiding pitfalls and preventing adverse
outcomes / M. U. Siddiqui, A. Ahmed, M. D. Siddiqui, A. K. Pasha // Clinical medicine
and research. – 2020. – Vol. 18, № 4. – P. 117–119.
70. Myocardial infarction with non-obstructive coronary arteries: a focus on
vasospastic angina / M. A. Beijk, W. V. Vlastra, R. Delewi [et al.] //
Netherlands heart journal. – 2019. – Vol. 27, № 5. – P. 237–245.
71. Myocardial infarction. Community registers: results of WHO international
collaborative study coordinated by the Regional office for Europe, Geneva, 1975 / Z.
Januškevičius, J. Blužas, J. Jankevičiūtė [et al.]. – Copenhagen : WHO, 1976. – 232 p.
72. Niccoli, G. Acute myocardial infarction with no obstructive coronary
atherosclerosis: mechanisms and management / G. Niccoli, G. Scalone, F. Crea //
European heart journal. – 2015. – Vol. 36, № 8. – P. 475–481.
73. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of
the Joint International Society and Federation of Cardiology/ World Health Organization
task force on standardization of clinical nomenclature // Circulation. – 1979. – Vol. 59,
№ 3. – P. 607–609.
https://t.me/med1917
157
74. Obraztsov, V. P. The symptomatology and diagnosis of coronary thrombus
/ V. P. Obraztsov, N. D. Strazhesko // Works of first Congress of Russian Therapists /
eds.: V. A. Vorobeva, M. P. Konchalovski. – M. : Comradeship typography of A. E.
Mamontov, 1910. – № 2. – P. 26–43.
75. OCT and CMR for the diagnosis of patients presenting with MINOCA and
suspected epicardial causes / E. Gerbaud, F. Arabucki, H. Nivet [et al.] // JACC.
Cardiovascular imaging. – 2020. – Vol. 13, № 12. – P. 2619–2631.
76. Osler, W. The principle and practice of medicine: designed for the use of
practitioners and students of medicine / W. Olser. – New York : D. Appleton and
Company, 1892. – 1079 p.
77. Outcomes with type 2 myocardial infarction compared with non-ischaemic
myocardial injury / G. Cediel, M. Gonzalez-Del-Hoyo, A. Carrasquer [et al.] // Heart. –
2017. – Vol. 103, № 8. – P. 616–622.
78. Perioperative myocardial infarction / G. Landesberg, W. Scott Beattie, M.
Mosseri [et al.] // Circulation. – 2009. – Vol. 119, № 22. – P. 2936–2944.
79. Perioperative myocardial infarction/injury after noncardiac surgery / C.
Puelacher, G. Lurati-Buse, H. Singeisen [et al.] // Swiss medical weekly. – 2015. – Vol.
145. – P. w14219.
80. Predicting coronary heart disease using risk factor categories for a Japanese
urban population, and comparison with the framingham risk score: the suita study / K.
Nishimura, T. Okamura, M. Watanabe [ et al.] // Journal of atherosclerosis and
thrombosis. – 2014. – Vol. 21, № 8. – P. 784–798.
81. Prognostic implications of type 2 myocardial infarctions / H. El-Haddad, E.
Robinson, K. Swett, G. L. Wells // World journal of cardiovascular diseases. – 2012. –
Vol. 2, № 4. – P. 237–241.
82. Provoking conditions, management and outcomes of type 2 myocardial
infarction and myocardial necrosis / N. R. Smilowitz, M. C. Weiss, R. Mauricio [el al.] //
International journal of cardiology. – 2016. – Vol. 218. – P. 196–201.
83. Sandoval, Y. Myocardial infarction type 2 and myocardial injury / Y.
Sandoval, K. Thygesen // Clinical chemistry. – 2017. – Vol. 63, № 1. – P. 101–107.
https://t.me/med1917
158
84. Sandoval, Y. Type 2 myocardial infarction: JACC review topic of the week
/ Y. Sandoval, A. S. Jaffe // Journal of the American College of Cardiology. – 2019. –
Vol. 73, № 14. – P. 1846–1860.
85. Sensitive troponin assay and the classification of myocardial infarction / A.
S. Shah, D. A. McAllister, R. Mills [et al.] // The American journal of medicine. – 2015.
– Vol. 128, № 5. – P. 493–501.
86. Sones, F. M. Jr. Cine coronary arteriography / F. M. Jr. Sones, E. K. Shirey
// Modern concepts of cardiovascular disease. – 1962. – Vol. 31. – P. 735–738.
87. Supply/demand type 2 myocardial infarction: should we be paying more
attention? / Y. Sandoval, S. W. Smith, S. E. Thordsen, F. S. Apple //
Journal of the American College of Cardiology. – 2014. – Vol. 63, № 20. – P. 2079–
2087.
88. Tehrani, D. M. Third universal definition of myocardial infarction: update,
caveats, differential diagnoses / D. M. Tehrani, A. H. Seto // Cleveland Clinic journal of
medicine. – 2013. – Vol. 80, № 12. – P. 777–786.
89. The diagnostic challenges associated with type 2 myocardial infarction / T.
Abe, I. Samuel, E. Eferoro [et al.] / International journal of applied and basic medical
research. – 2021. – Vol. 11, № 3. – P. 131–138.
90. The variation in recovery: role of gender on outcomes of young AMI patients
(VIRGO) classification system: a taxonomy for young women with acute myocardial
infarction / E. S. Spatz, L. A. Curry, F. A. Masoudi [et al.] // Circulation. – 2015. – Vol.
132, № 18. – P. 1710–1718.
91. Third universal definition of myocardial infarction / K. Thygesen, J. S.
Alpert, A. S. Jaffe [et al.] ; Joint ESC/ACCF/AHA/WHF Task Force for Universal
Definition of Myocardial Infarction // Journal of the American College of Cardiology. –
2012. – Vol. 60, № 16. – P. 1581–1598.
92. Thygesen, K. Detecting myocardial infarction type 2: targetting the right
patients / A. Thygesen, A. S. Jaffe // European heart journal. – 2017. – Vol. 38, № 47. –
P. 3521–3522.
https://t.me/med1917
159
93. Treatment and outcomes of type 2 myocardial infarction and myocardial
injury compared with type 1 myocardial infarction / N. R. Smilowitz, P. Subramanyam,
E. Gianos [et al.] // Coronary artery disease. – 2018. – Vol. 29, № 1. – P. 46–52.
94. Treatment and prognosis of myocardial infarction outside cardiology
departments / A. Gard, B. Lindahl, N. Hadziosmanovic, T. Baron // Journal of clinical
medicine. – 2020. – Vol. 10, № 1. – Article 106.
95. Type 1 or type 2 myocardial infarction in patients with a history of coronary
artery disease: Data from the Emergency Department / A. Putot, M. Jeanmichel, F.
Chagué [et al.] // Journal of clinical medicine. – 2019. – Vol. 8, № 12. – Article 2100.
96. Type 2 myocardial infarction in clinical practice / T. Baron, K. Hambraeus,
J. Sundström [et al.] // Heart. – 2015. – Vol. 101, № 2. – P. 101–106.
97. Type 2 myocardial infarction in general medical wards: Clinical features,
treatment, and prognosis in comparison with type 1 myocardial infarction / N. Furie, A.
Israel, L. Gilad [et al.] // Medicine. – 2019. – Vol. 98, № 41. – P. e17404.
98. Type 2 myocardial infarction: a geriatric population–based model of
pathogenesis / A. Putot, M. Jeanmichel, F. Chague [et al.] // Aging and disease. – 2020.
– Vol. 11, № 1. – P. 108–117.
99. Type 2 myocardial infarction: incidence, presentation, treatment and
outcome in routine clinical practice / D. Radovanovic, T. Pilgrim, B. Seifert [et al.] //
Journal of cardiovascular medicine. – 2017. – Vol. 18, № 5. – P. 341–347.
100. Type II myocardial infarction: predisposing factors, precipitating elements,
and outcomes / B. Pillai, S. Trikkur, U. Farooque [et al.] // Cureus. – 2020. – Vol. 12, №
7. – P. e9254.
101. Type-II myocardial infarction – patient characteristics, management and
outcomes / G. Y. Stein, G. Herscovici, R. Korenfeld [et al.] // PLoS one. – 2014. – Vol.
9, № 1. – P. e84285.
102. Universal definition of myocardial infarction / K. Thygesen, J. S. Alpert, H.
D. White [et al.] ; Joint ESC/ACC/AHA/WHF Task Force for the Redefinition of
Myocardial Infarction // Circulation. – 2007. – Vol. 116, № 22. – P. 2634–2653.
https://t.me/med1917
160
103. Vasospastic angina: A literature review of current evidence / F. Picard, N.
Sayah, V. Spagnoli [et al.] // Archives of cardiovascular diseases. – 2019. – Vol. 112, №
1. – P. 44–55.
104. Wake Forest University long-term follow-up of type 2 myocardial infarction:
The Wake-Up T2MI Registry / H. R. Jogu, S. Arora, M. Vaduganathan [et al.] // Clinical
cardiology. – 2010. – Vol. 42, № 6. – P. 592–604.
105. Waller, A. D. Introductory address on the electromotive properties of the
human heart / A. D. Waller // British medical journal. – 1888. – Vol. 2, № 1449. – P. 751–
754.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана